| Sun Pharmaceutical Industries Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524715 |
NSE Symbol : SUNPHARMA |
P/E(TTM) : 92.66 |
|
ISIN Demat : INE044A01036 |
Div & Yield% : 0.89 |
EPS(TTM) : 19.48 |
|
Book Value(₹) : 99.25 |
Market Cap(₹Cr) : 433,067.97 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 23,003.33 | 20,275.17 | 20,812.14 | 15,585.98 | 14,116.05 |
| Other Income | 623.97 | 553.48 | 329.29 | 1,196.88 | 192.07 |
| Stock Adjustments | 69.17 | -180.32 | 237.93 | 183.18 | 179.64 |
| Total Income | 23,696.47 | 20,648.33 | 21,379.36 | 16,966.04 | 14,487.76 |
| EXPENDITURE : | |||||
| Raw Materials | 6,050.20 | 5,423.79 | 6,292.09 | 5,833.57 | 5,287.12 |
| Power and Fuel Cost | 435.72 | 450.42 | 495.21 | 422.33 | 384.16 |
| Other Manufacturing Expenses | 1,261.72 | 1,195.30 | 1,037.32 | 1,064.32 | 862.12 |
| Selling and Administration Expenses | 5,539.89 | 4,754.86 | 4,326.42 | 3,514.05 | 3,309.62 |
| Miscellaneous Expenses | 638.63 | 615.66 | 3,257.27 | 2,086.08 | 479.24 |
| Employee Benefit Expenses | 2,608.26 | 2,373.95 | 2,156.95 | 2,000.78 | 1,805.98 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 7,162.05 | 5,834.35 | 3,814.10 | 2,044.91 | 2,359.52 |
| Interest | 893.21 | 784.08 | 472.18 | 388.10 | 267.52 |
| Gross Profit | 6,268.84 | 5,050.27 | 3,341.92 | 1,656.81 | 2,092.00 |
| Depreciation | 1,238.27 | 1,600.62 | 1,600.87 | 1,349.95 | 1,236.43 |
| Profit Before Tax | 5,030.57 | 3,449.65 | 1,741.05 | 306.86 | 855.57 |
| Current Tax | 908.62 | 546.10 | 752.77 | -553.58 | 244.91 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -160.67 | 45.37 | -702.44 | 960.43 | -231.74 |
| Reported Net Profit | 4,282.62 | 2,858.18 | 1,690.72 | -99.99 | 842.40 |
| Extraordinary Items | 7.08 | -193.46 | -2,181.63 | -1,263.25 | -63.64 |
| Adjusted Net Profit | 4,275.54 | 3,051.64 | 3,872.35 | 1,163.26 | 906.04 |
| Adjustment below Net Profit | -11.87 | -19.86 | 7.38 | -14.53 | 2,675.94 |
| Profit/Loss Balance carried down | 12,731.04 | 12,790.88 | 13,612.08 | 15,964.55 | 14,005.27 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 3,613.97 | 2,898.16 | 2,519.30 | 2,237.95 | 1,559.06 |
| P & L Balance carried down | 13,387.82 | 12,731.04 | 12,790.88 | 13,612.08 | 15,964.55 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,600.00 | 1,350.00 | 1,150.00 | 1,000.00 | 750.00 |
| Dividend Per Share(Rs) | 16.00 | 13.50 | 11.50 | 10.00 | 7.50 |
| Earnings Per Share-Unit Curr | 17.85 | 11.91 | 7.05 | -0.42 | 3.51 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 101.45 | 98.76 | 98.98 | 102.48 | 112.28 |
| Book Value(Adj)-Unit Curr | 101.45 | 98.76 | 98.98 | 102.48 | 112.28 |